The natural isoquinoline alkaloid berberine exhibits a wide spectrum of biological activities including antitumor activity, but its mechanism of action remains to be fully elucidated. Here, we report that berberine induced apoptosis in human melanoma cells, through a process that involved mitochondria and caspase activation. Berberine-induced activation of a number of caspases, including caspases 3, 4, 7, 8, and 9. Pan-caspase inhibitor, z-VAD-fmk, and caspase-8 and caspase-9 inhibitors prevented apoptosis. Berberine also led to the generation of the p20 cleavage fragment of BAP31, involved in directing proapoptotic signals between the endoplasmic reticulum and the mitochondria. Treatment of SK-MEL-2 melanoma cells with berberine induced disruption of the mitochondrial transmembrane potential, release of cytochrome c and apoptosis-inducing factor from the mitochondria to the cytosol, generation of reactive oxygen species (ROS), and a decreased ATP/ADP ratio. Overexpression of bcl-x L by gene transfer prevented berberine-induced cell death, mitochondrial transmembrane potential loss, and cytochrome c and apoptosis-inducing factor release, but not ROS generation. N-acetyl-L-cysteine inhibited the production of ROS, but did not abrogate the berberine-induced apoptosis. Inhibition of extracellular signal-regulated kinase (ERK) phosphorylation, by using the mitogen-activated protein kinase/ERK kinase inhibitor PD98059, and reduction of B-RAF levels by silencing RNA induced cell death of SK-MEL-2 cells, and diminished the berberine concentration required to promote apoptosis. These data show that berberine-induced apoptosis in melanoma cells involves mitochondria and caspase activation, but ROS generation was not essential. Our results indicate that inhibition of B-RAF/ERK survival signaling facilitates the cell death response triggered by berberine.
Introduction
Berberine, also known as Natural Yellow 18 (5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo (5,6-a) quinolizinium), is a benzyl tetra isoquinoline alkaloid extracted from Hidrastis canadensis (goldenseal), Coptis chinensis (coptis or goldenthread), Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), and Berberis aristata (turmeric tree) [1] . Berberine has a remarkable spectrum of biological activities including anti-inflammatory [2] , antimicrobial [3] , hypolipidemic [4] , hypoglycemic [5] , antiviral [6] , and antidepressant effects [7] . Berberine also proved to be an effective in-vitro and in-vivo antitumor agent against a wide variety of human cancer cells including tongue squamous carcinoma [8, 9] , nasopharyngeal carcinoma [10] , breast cancer [11] , hepatoma [12] , prostate cancer [13] , osteosarcoma [14] , lung cancer [15] , gastric carcinoma [16] , neuroblastoma [17] , and brain cancer [18, 19] cells. Berberine also exerts cytostatic activity against murine melanoma cell lines [20, 21] , this action is attributed to selective mitochondrial accumulation and dysfunction [22] . Assays on isolated mitochondria showed that berberine acted on the adenine nucleotide translocator to induce the mitochondrial permeability transition [23] , and promoted oxidative stress by interfering with a site located at or close to complex I [22] . However, the ability of berberine to prompt apoptosis in melanoma cells remains to be elucidated.
Melanoma is the most dangerous type of skin cancer. Metastatic malignant melanoma has a very poor prognosis with a low survival rate, being refractory to current therapies [24, 25] . Therefore, search for new therapeutic approaches is needed. The incidence and mortality rates of All supplemental digital content is available directly from the corresponding author.
this type of cancer increase every year. Natural compounds with potential cytotoxic and/or cytostatic effects on melanoma could be a good therapeutic option, as many phytochemical-based compounds are considered as relatively nontoxic, inexpensive, and available as oral forms [26] .
Berberine has been reported to promote G 1 and G 2 cell cycle arrest in distinct cell lines [16, 21, [27] [28] [29] . In this study, we report that berberine induces apoptosis in human melanoma cells through a caspase-dependent and mitochondrial-dependent mechanism. In addition, we have found that B-RAF/extracellular signal-regulated kinase (ERK) signaling plays a major role in the susceptibility of melanoma cells to undergo berberine-induced apoptosis, which could be of potential therapeutic value.
Materials and methods

Materials
Berberine hemisulfate salt was obtained from Sigma-Aldrich (St Louis, Missouri, USA) and prepared in dimethyl sulfoxide. The total volume of vehicle dimethyl sulfoxide in the distinct assays was less than 0.1-0.5%, which had negligible effects in all the experiments. Propidium iodide, ribonuclease A, bovine serum albumin, N-acetyl-L-cysteine (NAC), and 3,3,9-dihexyloxacarbocyanine iodide [DiOC 6 (3)] were from Sigma-Aldrich. Pan-caspase inhibitor, z-VAD-fmk, was from Alexis Biochemicals (Lausen, Switzerland). Caspase-8 inhibitor, z-IETD-fmk, caspase-9 inhibitor, z-LEHD-fmk, and mitogen-activated protein kinase/ERK kinase (MEK) inhibitor, PD98059, were from Calbiochem (Gibbstown, New Jersey, USA). Acrylamide/bisacrylamide, ammonium persulfate, and N,N,N 0 ,N 0 -tetramethylethylenediamine were obtained from Bio-Rad (Hercules, California, USA). Hoechst 33342 and dihydroethidine (DHE) were from Molecular Probes (Carlsbad, California, USA). Lipofectamine 2000 reagent was from Invitrogen (Eugene, Oregon, USA). RPMI-1640, fetal bovine serum (FBS), antibiotics, L-glutamine, sodium pyruvate, nonessential amino acids, and 0.25% trypsin-EDTA were purchased from Gibco (Carlsbad, California, USA).
Cell culture
Human melanoma cell lines SK-MEL-2, SK-MEL-5, SK-MEL-28, and MALME-3M, obtained from the American Type Culture Collection (Manassas, Virginia, USA), were grown in RPMI-1640 supplemented with 15% heatinactivated FBS, 2 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, 1% nonessential amino acids, 100 units/ml penicillin, and 100 mg/ml of streptomycin at 371C in 5% CO 2 humidified air. Cells were periodically tested for mycoplasma infection and were found to be negative.
Analysis of cell cycle and apoptosis by flow cytometry
Quantitation of apoptotic cells was determined by flow cytometry as the percentage of cells in the sub-G 1 region (hypodiploidy) in cell cycle analysis as described earlier [30] , using a FACScalibur flow cytometer (Becton Dickinson, San Jose, California, USA).
Western blotting in cell extracts
Cells at approximately 70% of confluence (approximately 1.0 Â 10 6 ) were lysed in 60 ml of 25 mmol/l Hepes (pH 7.7), 0.3 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 0.2 mmol/l EDTA, 0.1% Triton X-100, 20 mmol/l b-glycerophosphate, and 0.1 mmol/l sodium orthovanadate supplemented with protease inhibitors (1 mmol/l phenylmethylsulfonyl fluoride, 20 mg/ml aprotinin, 20 mg/ml leupeptin). Fifty micrograms of protein extract were run on SDS-polyacrylamide gels, transferred to Hybond enhanced chemiluminescence (ECL) nitrocellulose membranes (GE Healthcare, Princeton, New Jersey, USA), blocked with 5% (w/v) powder defatted milk in Tris-buffered saline with Tween 20 (50 mmol/l Tris-HCl, pH 8.0, 150 mmol/l NaCl, 0.1% Tween 20) for 60 min at room temperature, and incubated for 1 h at room temperature or overnight at 41C with the following specific antibodies: anti-17 and 19 kDa active caspase-3 rabbit polyclonal antibody (1 : 750 dilution), and 1C12 anti-57 kDa caspase-8 mouse monoclonal antibody, which also detects the cleaved p43 and p18 subunits (1 : 500 dilution) (Cell Signaling Technology, Beverly, Massachusetts, USA); N-15 anti-50 kDa caspase-4 goat polyclonal antibody, which also detects the active cleaved p20 subunit (1 : 250 dilution), C-15 anti-31 kDa BAP31 goat polyclonal antibody, which also detects the 20 kDa cleavage product (1 : 500 dilution), F-7 anti-84 kDa anti-B-RAF mouse monoclonal antibody (1 : 750 dilution), and anti-42 and 44 kDa phosphorylated ERK mouse monoclonal antibody (1 : 750 dilution) (Santa Cruz Biotechnology, Santa Cruz, California, USA); anti-35 kDa caspase-7 mouse monoclonal antibody, which also recognizes the cleaved p11, p20, and p32 subunits (1 : 750 dilution), C2.10 anti-116 kDa poly(ADP-ribose) polymerase mouse monoclonal antibody, which also detects the 85 kDa cleavage product (1 : 750 dilution), and anti-26 kDa Bcl-X rabbit polyclonal antibody (1 : 250) (BD Biosciences, San Jose, California, USA), and anti-47 kDa caspase-9 rabbit polyclonal antibody, which also recognizes the cleaved p10, p17, and p38 subunits (1 : 250 dilution, Calbiochem); AC-15 anti-42 kDa b-actin mouse monoclonal antibody (1 : 5000 dilution, Sigma). Secondary antibodies were anti-mouse biotinylated (GE Healthcare), anti-rabbit biotinylated (GE Healthcare), and anti-goat horseradish peroxidase (Santa Cruz Biotechnology). When secondary biotinylated antibodies were used, membranes were subsequently incubated with streptavidin-horseradish peroxidase conjugate (GE Healthcare). Signals were detected using an ECL kit (GE Healthcare).
Analysis of mitochondrial protein release
Release of proapoptotic proteins from the mitochondria to the cytosol was analyzed by western blot as described earlier [31] . In brief, cells (3 Â 10 6 ) were harvested, washed with ice-cold PBS, and gently lysed for 30 s in 50 ml of an ice-cold buffer containing 250 mmol/l sucrose, 1 mmol/l EDTA, 25 mmol/l Tris (pH 6.8), 0.05% digitonin, 1 mmol/l DTT, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 0.1 mmol/l phenylmethylsulfonyl fluoride. Lysates were centrifuged at 13 000 Âg for 3 min at 41C. Supernatant contained the cytosolic fraction, free of the mitochondria, and the pellet contained mostly nuclei and mitochondria. Pellets were resuspended in 50 ml of the above ice-cold buffer and spun down at 13 000 Â g for 10 s at 41C to sediment nuclear fraction, and the supernatants were centrifuged at 13 000 Â g for 3 min at 41C. These resulting pellets were enriched in the mitochondria and were resuspended in 20 ml of the above ice-cold buffer. Fifty micrograms of proteins of cytosolic fraction were electrophoresed by SDS-15% polyacrylamide gels, transferred onto a hybond ECL nitrocellulose membranes, blocked with 5% (w/v) powder defatted milk in Tris-buffered saline with Tween 20 for 60 min at room temperature, and incubated overnight at 41C with the specific antibodies given below: anti-15 kDa cytochrome c mouse monoclonal antibody (1 : 500 dilution, BD Biosciences); anti-67 kDa apoptosis-inducing factor (AIF) rabbit polyclonal antibody (1 : 500 dilution, BD Biosciences); and AC-15 anti-42 kDa b-actin monoclonal antibody (1 : 5000 dilution, Sigma). Then, the blots were incubated with biotinylated anti-mouse and anti-rabbit inmunoglobulin antibodies (GE Healthcare), followed by incubation with streptavidin-horseradish peroxidase conjugate (GE Healthcare). Signals were developed using an ECL kit (GE Healthcare).
Quantification by high-performance liquid chromatography of intracellular adenine nucleotides
An acid extraction procedure was used to evaluate the intracellular concentration of adenine nucleotides as described earlier [22] . Adenine nucleotides were separated by reverse-phase high-performance liquid chromatography. The chromatographic apparatus used was a Beckman-System Gold (Beckman Coulter, Fullerton, California, USA), consisting of a 126 Binary Pump Model and a 166 Variable UV detector, controlled by a computer. The detection wavelength was 254 nm, and the column was a Lichrospher 100RP-18 (5 mm) from Merck (Darmstadt, Germany). An isocratic elution with 100 mmol/l phosphate buffer, pH 6.5, and 1% methanol was performed with a flow rate of 1.1 ml/min. The required time for each analysis was 5 min. Quantification was achieved by using ATP, ADP, and AMP standard curves. Energy charge was calculated as [ATP + 0.5(ADP)/ATP + ADP + AMP].
Flow cytometry analysis of mitochondrial transmembrane potential and oxidative stress
Dissipation of the mitochondrial transmembrane potential (DC m ) and generation of reactive oxygen species (ROS) were evaluated by incubating cells in PBS for 40 min at 371C with 20 nmol/l DiOC 6 (3) (green fluores-cence) and 2 mmol/l DHE (red fluorescence after oxidation), respectively, followed by analysis on a FACScalibur flow cytometer as described earlier [30] .
Confocal microscopy
SK-MEL-2 cells in glass-bottom dishes were incubated
with 75 mmol/l berberine for 24 h. DHE (2 mmol/l) and Hoechst 33342 (2 mg/ml) were added to the cell culture 40 and 30 min before the end of drug treatment, and then the cells were analyzed by confocal microscopy using a Leica laser scanning confocal microscope (Bannockburn, Illinois, USA). The antifading reagent SlowFade Gold (Invitrogen) was used to preserve fluorescence signal intensity.
Cell transfection with bcl-x L SK-MEL-2 cells were transfected with 8 mg of pSFFV-Neo expression vector containing the human bcl-x L open reading frame driven by the long terminal repeat of the splenic focus-forming virus (pSFFV-Bcl-X L ) [32] , using Lipofectamine reagent (Invitrogen) and according to the manufacturer's instructions. As a control, transfection was performed with empty pSFFV-Neo plasmid. Transfectants were selected by growth in complete culture medium supplemented with 800 mg/ml G418 (Sigma, St Louis, Missouri, USA), and then grown in the presence of 250 mg/ml G418. Stable transfectants were achieved after approximately 30 days. The different clones were isolated and monitored for Bcl-X L expression by western blot, using the anti-26 kDa Bcl-X rabbit polyclonal antibody (1 : 250 dilution, BD Biosciences).
siRNA-mediated downregulation of B-RAF
Three 21-base B-RAF-specific siRNA sequences, from v-raf murine sarcoma viral oncogene homolog B1, locus ID 673, were synthesized by Applied Biosystem/Ambion (Foster City, California, USA): siRNA1 (sense: 5 0 -CAGU UGUCUGGAUCCAUUUtt-3 0 , antisense: 5 0 -AAAUGGAU CCAGACAACUGtt-3 0 ), siRNA2 (sense: 5 0 -GCAUAAUC CACCAUCAAUAtt-3 0 , antisense: 5 0 -UAUUGAUGGUGG AUUAUGCtc-3 0 ), siRNA3 (sense: 5 0 -CAGAGGAUUUUA GUCUAUAtt-3 0 , antisense: 5 0 -UAUAGACUAAAAUCCU CUGtt-3 0 ). For siRNA-mediated downregulation of B-RAF, SK-MEL-2 cells were seeded at 10 5 cells/well in complete cell culture medium in six-well plates on the day before transfection. Cells were then transfected in 1 ml RPMI-1640 culture medium in the absence of serum and antibiotics with 20 nmol/l B-RAF-specific siRNA1, siR-NA2 or siRNA3, or 20 nmol/l scramble siRNA (control siRNA) with 10 mg/ml lipofectamine (Invitrogen) according to the manufacturer's instructions. After 5 h, 1 ml of RPMI medium containing 10% FBS was added, and the cells were cultured for 48 h with or without the drug, and then the cells were harvested and lysed for analysis. The siRNA2 sequence showed the highest efficiency in downregulating B-RAF.
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Statistical analysis
Data are expressed as means ± standard deviation of the number of experiments indicated in the respective figure legends. Multiple comparisons were made using one-way analysis of variance followed by a Bonferroni post-hoc test. Statistical comparisons between the two experimental groups were made using Student's t-test. Significance was accepted at a P value of less than 0.05.
Results
Berberine induces caspase-dependent apoptosis in human melanoma cells
We observed that the treatment of human metastatic SK-MEL-2 melanoma cells with berberine at 10, 25, or 50 mmol/l for 24 and 48 h failed to elicit a significant cell death (data not shown). However, treatment of SK-MEL-2 cells with 75 mmol/l berberine for 48 h resulted in the induction of apoptosis, as assessed by the presence of cells in the sub-G 1 region (hypodiploidy) in cell cycle analysis ( Fig. 1a ), in a time-dependent manner ( Fig. 1b ). We also noticed that 75 mmol/l berberine induced apoptosis in additional human melanoma cell lines after 48 h incubation including (percentage apoptosis in parentheses): SK-MEL-5 (37.28 ± 9.20%), SK-MEL-28 (17.65 ± 5.10%), and MALME-3M (30.72 ± 7.35%).
Berberine-induced apoptosis of SK-MEL-2 cells involved a time-dependent activation of caspases 3, 4, 7, 8, and 9, as assessed by the appearance of the respective cleaved active caspases ( Fig. 2a ). Drug-induced cell death was abrogated by preincubation of SK-MEL-2 cells with the pan-caspase inhibitor, z-VAD-fmk, (Fig. 2b) , thus indicating the involvement of caspase activation in berberineinduced apoptosis. In addition, caspase-8 inhibitor, z-IETD-fmk, and caspase-9 inhibitor, z-LEHD-fmk, also inhibited apoptotic response ( Fig. 2b) . Interestingly, berberine treatment led to the generation of the p20 caspase-cleavage fragment of BAP31 ( Fig. 2a) , an integral protein of the endoplasmic reticulum that is a caspase-8 substrate [33] and links proapoptotic signals between the endoplasmic reticulum and the mitochondrion [34] . Fig. S1 ) shows clearly that SK-MEL-2 cells stop dividing in the presence of berberine, and undergo typical morphological changes of apoptosis (blebbing, cell shrinkage, rounding up).
Time-lapse videomicroscopy (Supplementary
Berberine induces DC m disruption, cytochrome c release, and ROS generation
Berberine treatment led to ROS generation in SK-MEL-2 cells, as detected by flow cytometry and confocal microscopy, using DHE (nonfluorescent) that becomes ethidium (red fluorescence) after its oxidation by ROS (Fig. 3a) . Mitochondrial depolarization was also detected in berberine-treated cells by using the cationic probe (Fig. 3b ) or tetramethylrhodamine methylester (data not shown), which accumulate into the polarized mitochondria as a function of DC m . Following a timecourse, we detected disruption of DC m after 8 h incubation (Fig. 3b) , which was accompanied by the onset of apoptosis (Fig. 1b ). We found that both DC m disruption and the trigger of apoptosis were rather simultaneous ( Fig. 3a, 1b , and data not shown). Berberine also induced cytochrome c and AIF release from the mitochondria to the cytosol (Fig. 3c) , and decreased the ATP/ADP ratio and the cellular energy charge (Fig. 3d ).
Bcl-X L overexpression prevents cell death induced by berberine
As Bcl-X L preserves mitochondrial integrity [30, 35, 36] , we examined the effect of overexpressing Bcl-X L in SK-MEL-2 cells to further analyze the role of mitochondria in the antitumor effect of berberine on melanoma cells. We stably transfected SK-MEL-2 cells with pSFFV-bcl-x L (SK-MEL-2-Bcl-X L ), containing the human bcl-x L open reading frame, or with control pSFFV-Neo plasmid (SK-MEL-2-Neo). SK-MEL-2-Neo cells behaved as nontransfected SK-MEL-2 cells in all the parameters studied. Western blot analysis showed that SK-MEL-2-Neo cells expressed low levels of endogenous Bcl-X L , whereas a high expression of this protein was observed in SK-MEL-2-Bcl-X L cells (Fig. 4a, inset) . SK-MEL-2-Neo cells underwent apoptosis after treatment with berberine. However, overexpression of Bcl-X L by gene transfer in SK-MEL-2 cells totally blocked apoptosis after treatment with 75 mmol/l berberine for 48 h (Fig. 4a ), although an increase in the percentage of cells in the G 2 phase of cell cycle was observed (data not shown). Bcl-X L overexpression also abrogated the release of cytochrome c and AIF from the mitochondria (Fig. 4b) , and DC m dissipation (Fig. 4c ). Altogether, these results further show the involvement of the mitochondria in berberine-induced apoptosis. The oxidative stress response induced by berberine was slightly decreased upon Bcl-X L overexpression, but this inhibition was not statistically significant (P>0.05) ( Fig. 4d) , indicating that the ROS generation was not crucial for berberine-induced apoptosis.
Inhibition of ROS does not prevent berberine-induced apoptosis
The above data suggested that although berberine prompted the generation of ROS, these were not involved in berberine-induced apoptosis. This conclusion was further supported by the fact that incubation of SK-MEL-2 cells with the antioxidant NAC inhibited ROS generation (Fig. 5a ), but it did not prevent DC m disruption ( Fig. 5b) and apoptosis (Fig. 5c ) after berberine treatment.
Effect of MEK/ERK inhibition on berberine-induced cytotoxicity
Constitutive activation of the MEK-ERK signaling pathway is often found in melanomas [37] , and this activated signaling route has been suggested to be involved in the resistance of melanoma to treatment [38] . On these grounds, we used the selective and cell-permeable MEK inhibitor, PD98059, which inhibits ERK activation, to assess the involvement of ERK signaling in berberineinduced apoptosis. Incubation of SK-MEL-2 cells with 50 mmol/l PD98059 downregulated phosphorylated-ERK level, as assessed by immunofluorescence flow cytometry (data not shown). Interestingly, SK-MEL-2 cells became more sensitive to berberine after PD98059 pretreatment. MEK/ERK inhibition promoted a weak apoptotic response in SK-MEL-2 cells, and the percentage of apoptotic cells was highly increased subsequent to incubation with berberine at a concentration of 20 mmol/l, which by itself, in the absence of MEK/ERK inhibition, was unable to elicit cell death (Fig. 6a ). The high increase in sensitivity to berberine-induced cell death upon PD98059 pretreatment was also assessed by poly(ADP-ribose) polymerase breakdown (Fig. 6b ).
Effect of B-RAF silencing on berberine-induced cytotoxicity
B-RAF gene is mutated in approximately 70% of malignant melanomas, and has been suggested as a therapeutic target for melanoma [39] . Silencing B-RAF, by using siRNA, downregulated B-RAF expression ( Fig. 7a) and promoted apoptosis (Fig. 7b and c) . B-RAF silencing potentiated the apoptotic response induced by 20 mmol/l berberine, a concentration that was unable to induce significant apoptosis in the absence of B-RAF silencing (Fig. 7b and c ).
Discussion
The data reported here show that berberine induces apoptosis in human melanoma cells in a mitochondrialdependent and caspase-dependent manner. The induction of apoptosis by berberine involved activation of the intrinsic mitochondrial signaling pathway, as assessed by DC m dissipation, cytochrome c, and AIF release from the mitochondria, and the blockade of these processes by Bcl-X L overexpression. The intrinsic mitochondrial signaling pathway leads eventually to the cleavage of procaspase 9, initiating an enzymatic reaction cascade that results in the execution of apoptosis [40] . Here, we report that berberine induced caspase-9 activation, and inhibition of this caspase activity prevented apoptosis. Altogether, these data indicate that the mitochondria play a key role in berberine-induced apoptosis. Earlier studies have shown that berberine accumulated in the mitochondrion [21, 22] . Thus, mitochondria are mainly involved in the antitumor action of berberine. In this regard, Patil et al. [41] have recently reported a correlation between the induction of apoptosis and an increase in the levels of cytoplasmic cytochrome c and caspase-9 activity in MCF-7 breast cancer cells, after berberine treatment, further supporting a major involvement of mitochondria in the antitumor mechanism of action of berberine.
The results reported here also indicate that berberine treatment promoted oxidative stress. Bcl-X L overexpression Bcl-X L -transfected SK-MEL-2 cells (Bcl-X L ) were treated with 75 mmol/l berberine for 24 h, and then analyzed for ROS generation using dihydroethidine. Untreated control cells (C) were run in parallel. Data shown are means ± standard deviation of four independent experiments, or are representative of three experiments performed. Values that are statistically different from untreated control cells at P less than 0.05 (*) and at P value less than 0.01 (**), and from berberine-treated cells at P value less than 0.05 ( w ) and P value less than 0.01 ( ww ) are indicated.
Signaling in berberine anticancer action Burgeiro et al. 513 abrogated berberine-induced DC m loss and, cytochrome c and AIF release from the mitochondria, but was unable to inhibit the production of ROS in a statistically significant manner. This suggests that the production of ROS might be, at least in part, because of a direct effect of berberine on the respiratory chain. In this context, berberine has been shown to inhibit mitochondrial complex I and increase complex I-dependent generation of ROS [21, 22] . As Bcl-X L overexpression abrogated berberine-induced cell death, but not ROS generation, our data suggest that oxidative stress is a side effect of berberine action, and is not essential for the apoptotic response induced by this drug. Furthermore, our data showing that the ROS scavenger NAC inhibited berberine-induced ROS production but not berberine-induced apoptosis, further confirmed that ROS generation was not involved in the apoptotic response triggered by berberine.
Our results provide novel insights into the mechanism of berberine-mediated antimelanoma activity. Thus, the data reported here suggest that induction of apoptosis is the major effect that underlies berberine antitumor action, at least in melanoma cells. Nevertheless, berberine treatment required both a high drug concentration and rather protracted incubation times to promote apoptosis. Thus, the use of different drug concentrations and cell types may explain the distinct effects on cell cycle and apoptosis observed after berberine treatment [16, 21, [27] [28] [29] . Our results showed that berberine promoted G 2 arrest when apoptosis was abrogated by Bcl-X L over-expression. This indicates that berberine affects the cell cycle, and this action is more evident when the apoptotic response was blocked. Signaling in berberine anticancer action Burgeiro et al. 515 These data also show that berberine induces cleavage of BAP31, a polytopic integral membrane protein of the endoplasmic reticulum that is part of a complex that contains Bcl-2/Bcl-X L and procaspase 8 [33] . This leads to the generation of the proapoptotic caspase-8-derived p20 fragment of BAP31, which enhances mitochondrial c release into the cytosol [34] , and acts as a linker between the endoplasmic reticulum and the mitochondria during apoptosis. Thus, it might be envisaged that the endoplasmic reticulum stress could amplify or contribute to the above berberine-induced mitochondrial-mediated apoptotic response. In this regard, inhibition of caspase 8, which acts on BAP31, inhibited berberine-induced apoptosis; and caspase 4 and caspase 7, which are associ ated with the endoplasmic reticulum [42] , were activated after berberine treatment.
A number of different signaling pathways and processes involved in cancer have been reported to be affected by berberine in mammalian cells, including p38 mitogenactivated protein kinase [43] , nuclear factor-kB [44] [45] [46] , and invasion mediated by urokinase-type plasminogen activator and metalloproteinases 2 and 9. In addition, berberine has been reported to activate the aryl hydrocarbon receptor (AhR) in hepatoma cells [47] . AhR has been suggested to predispose hepatocytes to Fas(CD95)mediated apoptosis [48] , and it has also been shown to have a proliferative and antiapoptotic action [49] , playing a putative role in tumor progression. Here, we have found that the MEK inhibitor, PD98059, potentiated berberineinduced apoptosis in melanoma cells. However, this inhibitor has also been reported to be an antagonist of AhR at concentrations commonly used to inhibit MEK [50] . Taken together, it could be envisaged that berberine may affect a plethora of signaling routes with opposing effects on cancer development. On these grounds, it could be hypothesized that berberine antitumor action might be enhanced by combining berberine with additional agents that prevent activation of cancer cell survival signaling pathways.
The RAS/RAF/MEK/ERK survival signaling pathway is constitutively activated in melanomas, and thus exerts several key functions in melanoma development and progression [51] . Constitutive activation of MEK-ERK signaling is often found in melanomas [37, 52] , and activating B-RAF mutations are present in 66% of melanomas, most of them (approximately 90%) involving codon 600 (earlier denoted codon 599) [53, 54] . Thus, the RAS/RAF/MEK/ ERK pathway may represent a promising therapeutic target in melanomas. We found that ERK inhibition or B-RAF silencing induced a weak apoptotic response in melanoma cells, which was dramatically increased by subsequent berberine treatment. Interestingly, once ERK was inhibited, berberine was able to induce a high apoptotic response in melanoma cells at lower concentrations. Similar results, although at a lower extent, were obtained with the combined action of B-RAF silencing and berberine. Thus, inhibition of RAS/RAF/MEK/ERK signaling seems to be crucial to improve the apoptotic effects of berberine, hence highlighting the importance of B-RAF/ERK signaling in the survival and treatment regimens of melanoma cells. SB-590885, a potent B-RAF kinase inhibitor, has been shown to exert a rather modest decrease in melanoma tumor growth in xenograft assays [55] . In our hands, the antimelanoma activity of berberine was much further potentiated by ERK inhibition than by B-RAF silencing. On these grounds, inhibition at the end of the RAS/RAF/MEK/ERK signaling cascade leads to a higher potentiation of the apoptotic response triggered by berberine in melanoma cells. Although the results reported here have been obtained using human cell lines, which are not often representative of their parent tumors, combi nation therapy between ERK signaling inhibitors and berberine might be of potential interest in the treatment of melanoma.
Conclusion
The data reported here show the involvement of mitochondria and caspase activation in berberine-induced apoptosis in melanoma cells, and point out the importance of B-RAF/ERK signaling in the survival and treat ment regimens of melanoma cells. Inhibition of B-RAF/ ERK survival signaling facilitates the cell death response triggered by berberine, providing novel insights into the mechanism of berberine-mediated antimelanoma activity. A putative involvement of endoplasmic reticulum stress is also considered to contribute to berberine-induced apoptotic response.
